Can daily adaptive radiotherapy spare healthy tissue in prostate cancer?
Disease control
Recruiting now
Researchers are testing whether daily adaptive radiotherapy, which adjusts the radiation plan to each day's anatomy, causes fewer bladder and bowel side effects than standard radiotherapy in people with intermediate or high risk localized prostate cancer. The trial also compares …
Phase 2 • Sponsor: Scott Tyldesley • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC